Skip to main content
. 2019 Jan 17;4(1):2381468318812889. doi: 10.1177/2381468318812889

Table 1.

Characteristics of All Study Participantsa

Total (N = 204) BCS-PtDA (n = 102) Control (n = 102)
Age (years), median (IQR) 40.0 (39.0, 42.0) 40.0 (39.0, 42.0) 40.0 (39.0, 42.0)
Missing 0 0 0
Lifetime breast cancer risk (NCI-BCRAT) (%), median (IQR) 9.7 (9.2, 11.1) 9.7 (9.1, 12.1) 9.6 (9.3, 10.7)
Missing 1 0 1
Lifetime breast cancer risk (NCI-BCRAT) categories, n (%)
 ≤12 162 (79.8) 76 (74.5) 86 (85.1)
 >12 to ≤20 34 (16.7) 21 (20.6) 13 (12.9)
 >20 7 (3.4) 5 (4.9) 2 (2.0)
Missing 1 0 1
Race, n (%)
 Black 132 (64.7) 60 (58.8) 72 (70.6)
 White 55 (27.0) 32 (31.4) 23 (22.5)
 Asian 6 (2.9) 4 (3.9) 2 (2.0)
 Hispanic 3 (1.5) 2 (2.0) 1 (1.0)
 Other/unknown 8 (3.9) 4 (3.9) 4 (3.9)
Clinic affiliation, n (%)
 Family practice 52 (25.6) 27 (26.5) 25 (24.8)
 Internal medicine 95 (46.8) 47 (46.1) 48 (47.5)
 Ob/Gyn 56 (27.6) 28 (27.5) 28 (27.7)
Missing 1 0 1
Mammography within 1 year, n (%)
 No 163 (79.9) 82 (80.4) 81 (79.4)
 Yes 41 (20.1) 20 (19.6) 21 (20.6)

BCS-PtDA, breast cancer screening patient decision-aid; IQR, interquartile range; NCI-BCRAT, National Cancer Institute Breast Cancer Risk Assessment Tool.

a

Percent computed among non-missing values. Lifetime breast cancer risk determined by the National Cancer Institute Breast Cancer Risk Assessment Tool.21,22